BRACX | FXICX | BRACX / FXICX | |
Total Expense Ratio | 0.00 | 0.27 | - |
Annual Report Gross Expense Ratio | 0.11 | 0.27 | 41% |
Fund Existence | 21 years | 26 years | - |
Gain YTD | 6.617 | 7.527 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 457M | 1.77B | 26% |
Annual Yield % from dividends | 5.32 | 5.41 | 98% |
Returns for 1 year | 3.60 | 4.95 | 73% |
Returns for 3 years | 18.01 | 20.90 | 86% |
Returns for 5 years | -2.48 | 4.80 | -52% |
Returns for 10 years | 30.43 | 32.16 | 95% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSSY | 20.03 | 0.16 | +0.81% |
Return Stacked U.S. Stocks & Futures Yield ETF | |||
CADUSD | 0.72 | N/A | N/A |
Canadian Dollar - United States Dollar | |||
BBBI | 52.30 | N/A | N/A |
BondBloxx BBB Rated 5-10 Yr Corp Bd ETF | |||
PSC | 55.90 | -0.13 | -0.23% |
Principal US Small Cap ETF | |||
PBE | 69.96 | -0.99 | -1.40% |
Invesco Biotechnology & Genome ETF |